top of page
Latest News
Real-World Study Led by Observational and Pragmatic Research Institute Suggests GLP-1 Receptor Agonists May Reduce COPD Exacerbation Risk in Patients with Type 2 Diabetes
An international real-world study coordinated by the Observational and Pragmatic Research Institute (OPRI) suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with fewer exacerbations and reduced corticosteroid use in patients living with chronic obstructive pulmonary disease (COPD) and type 2 diabetes (T2D). The findings, published in Pragmatic and Observational Research , are based on data from a large UK primary care population. COPD and
Mar 232 min read
PREVAIL Trial Protocol: Early Intervention in Modifiable High-Risk COPD
Our latest manuscript in the Journal of the COPD Foundation describes the protocol for PREVAIL , the first clinical trial to test...
Jun 3, 20252 min read
A recent study shows a surprising improvement in respiratory outcomes when patients with asthma receive weight loss drugs.
Singapore, [10 April 2025] – A large real world evidence study conducted by leading respiratory experts found patients with asthma who...
Apr 8, 20252 min read
Innovative analysis predicts steroid-related health risks for people with asthma
Singapore, [8 April 2025] – Groundbreaking research by the Observational and Pragmatic Research Institute (OPRI) has developed...
Apr 8, 20252 min read
Pioneering Study Reveals No Increased Pneumonia Risk in COPD Patients Using Extrafine Beclometasone Dipropionate in Inhaler Therapy
A ground-breaking study conducted by an international consortium of leading respiratory experts sheds new light on the management of COPD
Feb 21, 20242 min read
Observational and Pragmatic Research International Joins the Good Business Charter
Observational and Pragmatic Research International Limited is delighted to announce that it has signed up to the Good Business Charter (GBC)
Feb 2, 20243 min read
LANDMARK STUDY REVEALS ADVERSE OUTCOMES LINKED TO ORAL CORTICOSTEROID USE IN COPD PATIENTS
Singapore, [4 December 2023] - Results from a real-world research study have highlighted the risks associated with the long-term use of...
Dec 12, 20232 min read
bottom of page